Navigation Links
Reportlinker Adds The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
Date:10/8/2009

g Sales and Impact of Wellness Programs, 2004-2013

Table 3-11: U.S. OTC Gastrointestinal Drug Sales and Impact of Wellness Programs, 2004-2013

Table 3-12: U.S. OTC Smoking Cessation Drug Sales and Impact of Wellness Programs, 2004-2013

Table 3-13: U.S. OTC Weight Loss Drug Sales and Impact of Wellness Programs, 2004-2013

Table 3-14: Total U.S. OTC Drug Sales and Impact of Wellness Programs on Selected Drug Groups, 2004-2013

Figure 3-2: Impact of Wellness Programs on Selected OTC Drug Groups, 2004-2013

Table 3-15: U.S. Influenza Vaccine Sales and Impact of Wellness Progress 2004-2013

Table 3-16: U.S. Cervical Cancer Vaccine Sales and Impact of Wellness Programs, 2004-2013

Table 3-17: U.S. Vaccine Sales and Impact of Wellness Programs, 2004-2013

Figure 3-3: Impact of Wellness Programs on Vaccine Sales, 2004-2013

Table 3-18: U.S. POC Test Sales and Impact of Wellness Programs, 2004-2013

Table 3-19: U.S. Clinical Chemistry and Immunoassay Test Sales and Impact of Wellness Programs, 2004-2013

Table 3-20: U.S. Clinical Test Sales and Impact of Wellness Programs, 2004-2013

Figure 3-4: Impact of Wellness Programs on Clinical Diagnostic Tests, 2004-2013

Table 3-21: U.S. Cardiovascular Device Sales and Impact of Wellness Programs on Selected Drug Groups, 2004-2013

Table 3-22: U.S. Gastric Banding Device Sales and Impact of Wellness Programs, 2004-2013

Table 3-23: Selected U.S. Medical Device Sales and Impact of Wellness Programs, 2004-2013

Figure 3-5: Impact of Wellness Programs on Medical Devices, 2004-2013

Table 3-24: U.S. Surgical Intervention Revenues and Impact of Wellness Programs, 2004-2013

Table 3-25: U.S. Medical Imaging Revenues and Impact of Wellness Programs, 2004-2013

Table 3-26: Selected U.S. Medical Service Revenues and Impac
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... CDC,s Morbidity and Mortality Weekly Report (MMWR) released ... epidemiologists has decreased steadily since 2004, with a ... was also a substantial decrease in core epidemiology ... for bioterrorism and emergency response. For ... substance abuse, and oral health, basic epidemiology capacity ...
(Date:12/17/2009)... Good Samaritan Hospital is changing the way women manage ... of the Good Samaritan Hospital Women,s Center For Bladder ... help treat two common medical problems - lack of ... uterus or rectum (pelvic organ prolapse). Three out of ... one out of three may experience pelvic organ prolapse, ...
(Date:12/17/2009)... OAKLAND, Calif., Dec. 17 Today, SEIU ... that Alameda County In-Home Supportive Service (IHSS) providers ... contract with the County that adds multiple layers ... and benefit levels, as well as granting additional ... joining the Governor,s desire to slash homecare provider ...
(Date:12/17/2009)... WALTHAM, MA Brandeis University selected Jay and Maureen Neitz, ... the use of gene therapy to treat vision disorders, ... Award in Vision Sciences. , The award is funded ... a gift from Brandeis graduates Jay Pepose ,75 and ... supports graduate research fellowships in vision science. , The ...
(Date:12/17/2009)... hospital clients Rutherford Hospital Inc. (Rutherfordton, N.C.), a management ... management client since 1992, were recently recognized as top-ranked ... ... Brentwood, Tenn. (PRWEB) ... Rutherford Hospital Inc. (Rutherfordton, N.C.), a management client since ...
Breaking Medicine News(10 mins):Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3Health News:New Alameda County IHSS Contract Sends Clear Message to Elected Leaders That Homecare Program Must Remain a California Priority 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value 2
... The Procter & Gamble,Company (NYSE: PG ... New York City,beginning at 8:30 a.m. Eastern Time. ... and the Company,s executive management team will,provide a review ... growth opportunities. , ...
... commissioned insurance sales agents in Canada are on the rise ... ... recent reports by Statistics Canada that unemployment is growing and consumer ... supplemental insurance, reports job opportunities for commissioned insurance sales agents in ...
... ... Panama City, FL (PRWEB) December 11, 2008 -- iSirona®, an ... that Peter Witonsky has been named president and chief sales officer. ... over the past 12 months. Company founder and former President Dave ...
... of Electronic Medical Record and practice billing solutions for the healthcare ... company as Chief Commercial Officer. Flormann brings 25 years of ... business and market development to Glenwood Systems. , ... ...
... OH, December 11, 2008 -- More than half a million ... and preterm births are on the rise. Late preterm ... (approximately 4 to 6 weeks before the mother,s due date), ... the large number of affected babies, many people are unaware ...
... ACEL ) today reported its financial results for the first quarter ... company recorded a net loss of approximately $2.8 million, or $0.06 ... Oct. 31., compared to a net loss of $2.7 million, or ... of fiscal 2008. Research and development expenses increased by approximately ...
Other Medicine News:Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 3Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 4Health News:Insurance Job Opportunities Rise in Canada in Spite of Challenging Economy 2Health News:Insurance Job Opportunities Rise in Canada in Spite of Challenging Economy 3Health News:iSirona Announces New President and Chief Sales Officer 2Health News:Glenwood Systems, LLC Appoints Ron Flormann Chief Commercial Officer 2Health News:Late preterm births present serious risks to newborns 2Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 3Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 4Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 5
(Date:12/16/2009)... 17 Cell Therapeutics, Inc. (CTI) ... on February 10, 2010 the U.S. Food ... (ODAC) will review the New Drug Application ... relapsed/refractory aggressive non-Hodgkin,s lymphoma (NHL). ODAC is ... data concerning the efficacy and safety of ...
(Date:12/16/2009)... Medlytix, a national healthcare consulting firm, ... half-billion dollar milestone - the total amount of ... financial assistance to more than a half-million patients ... classifying charity care - in less than two ... hospitals enhanced their bottom lines and still were ...
(Date:12/16/2009)... Dec. 16 Ethicon, Inc., a Johnson ... and a worldwide leader in surgical care, and ... dedicated to designing, developing and commercializing devices that ... (ENT), today announced a definitive merger agreement whereby ... for approximately $785 million net of estimated cash ...
Breaking Medicine Technology:Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4Healthcare Scoring System Allows Hospitals To Increase Charity Care 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 4Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer 3A New Hotline Report to Aid Healthcare Decision Make 6429 1ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer 3A New Hotline Report to Aid Healthcare Decision Make 6429 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer 3A New Hotline Report to Aid Healthcare Decision Make 6429 3Biologists discover bacterial defense mechanism against aggressive oxygen 10837 1Biologists discover bacterial defense mechanism against aggressive oxygen 10837 2Lehigh receives grant to reduce cost of carbon capture at coal fired power plants 10833 1Lehigh receives grant to reduce cost of carbon capture at coal fired power plants 10833 2Lehigh receives grant to reduce cost of carbon capture at coal fired power plants 10833 3
... June 25 Vical Incorporated,(Nasdaq: VICL ) ... milestones under a three-year, $6.0 million grant awarded ... a DNA vaccine manufacturing,process with the potential to ... of days., The RapidResponse(TM) system is designed ...
... Initiates a Phase I/II Study of Zalutumumab in Combination, ... Head and Neck Cancer., COPENHAGEN, June 24 ... Phase I/II study of zalutumumab,(HuMax-EGFr(TM)) in combination with radiotherapy ... study will include a maximum of 36,patients who are ...
Other Medicine Technology:Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH 2Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH 3Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH 4Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH 5Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 2Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 3
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: